Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Health Discovery Corp. (HDVY : OTCBB)
 
 • Company Description   
Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology. The principal healthcare market for its pattern recognition technology and biomarker discoveries is medical diagnostics, particularly the field of molecular diagnostics.

Number of Employees: 3

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.03 Daily Weekly Monthly
20 Day Moving Average: 311,391 shares
Shares Outstanding: 401.58 (millions)
Market Capitalization: $13.73 (millions)
Beta: 2.81
52 Week High: $0.43
52 Week Low: $0.02
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -20.47% -12.91%
12 Week -30.06% -21.40%
Year To Date 36.80% 67.13%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2002 Summit Blvd NE Suite 300
-
Atlanta,GA 30319
USA
ph: 404-566-4865
fax: -
investor@healthdiscoverycorp.com http://www.healthdiscoverycorp.com
 
 • General Corporate Information   
Officers
George H. McGovern - Chairman and CEO
Marty Delmonte - President; Chief Operating Officer; Principal Fina
William F. Fromholzer - Director
Colleen M. Hutchinson - Director
Edward Morrison - Director

Peer Information
Health Discovery Corp. (CORR.)
Health Discovery Corp. (RSPI)
Health Discovery Corp. (CGXP)
Health Discovery Corp. (BGEN)
Health Discovery Corp. (GTBP)
Health Discovery Corp. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 42218R100
SIC: 6794
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/21
Next Expected EPS Date: 05/27/22
Share - Related Items
Shares Outstanding: 401.58
Most Recent Split Date: (:1)
Beta: 2.81
Market Capitalization: $13.73 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -473.24
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 0.33
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 0.33
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - 0.00
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©